TWD 62.7
(2.96%)
Year | Inventory | Inventory Growth |
---|---|---|
2023 | 42.17 Million TWD | 57.21% |
2022 | 26.82 Million TWD | 30.56% |
2021 | 20.54 Million TWD | -34.28% |
2020 | 31.26 Million TWD | 0.0% |
2019 | - TWD | 0.0% |
Year | Inventory | Inventory Growth |
---|---|---|
2024 Q2 | 148.29 Million TWD | 144.13% |
2024 Q1 | 60.74 Million TWD | 44.04% |
2023 Q4 | 42.17 Million TWD | -5.22% |
2023 FY | 42.17 Million TWD | 57.21% |
2023 Q3 | 44.49 Million TWD | 50.09% |
2023 Q2 | 29.64 Million TWD | -19.81% |
2023 Q1 | 36.96 Million TWD | 0.0% |
2022 FY | 26.82 Million TWD | 30.56% |
2022 Q4 | - TWD | 0.0% |
2021 FY | 20.54 Million TWD | -34.28% |
2020 FY | 31.26 Million TWD | 0.0% |
2019 FY | - TWD | 0.0% |
Name | Inventory | Inventory Difference |
---|---|---|
Allied Biotech Corporation | 601.47 Million TWD | 92.989% |
GeneFerm Biotechnology Co., Ltd. | 155.43 Million TWD | 72.869% |
TTY Biopharm Company Limited | 1.09 Billion TWD | 96.152% |
Synmosa Biopharma Corporation | 1.59 Billion TWD | 97.361% |
Orient EuroPharma Co., Ltd. | 1.09 Billion TWD | 96.152% |
Center Laboratories, Inc. | 269.22 Million TWD | 84.336% |
Tien Liang BioTech Co., Ltd. | 75.79 Million TWD | 44.362% |
Orient Pharma Co., Ltd. | 233.97 Million TWD | 81.976% |
InnoPharmax Inc. | 22.24 Million TWD | -89.592% |
Johnson Chemical Pharmaceutical Works Co., Ltd. | 138.8 Million TWD | 69.619% |
Excelsior Biopharma Inc. | 217.28 Million TWD | 80.591% |
DV Biomed Co., Ltd. | 96.51 Million TWD | 56.306% |
Foresee Pharmaceuticals Co., Ltd. | 126.79 Million TWD | 66.742% |
Handa Pharmaceuticals, Inc. | - TWD | -Infinity% |
UniPharma Co., Ltd. | 28.94 Million TWD | -45.699% |
Anxo Pharmaceutical Co., Ltd. | 283.86 Million TWD | 85.144% |
Alar Pharmaceuticals Inc. | - TWD | -Infinity% |
Winston Medical Supply Co., Ltd. | 115.73 Million TWD | 63.563% |
Mercury Biopharmaceutical Corporation | 10.07 Million TWD | -318.612% |
Bioray Biotech Co., Ltd | 55.95 Million TWD | 24.627% |
TSH Biopharm Corporation Limited | 118.39 Million TWD | 64.381% |